Michael Schamroth, Director at BIOSPECIFICS TECHNOLOGIES CORP (BSTC), sold 5,200 shares at $39.47 ($204K) on 2014-11-13, disclosed to the SEC on 2014-11-14.
Open-market sale of $204k BSTC by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $39.00 | 2,000 | $78K | 38.3% |
| 2 | $39.47 | 2,200 | $87K | 42.6% |
| 3 | $39.00 | 1,000 | $39K | 19.1% |
| Total | $39.20 avg | 5,200 | $204K | 100% |
| Filing → |
| BSTC | SELL | 2014-11-19 | $12K | — | Filing → |
| BSTC.PK | SELL | 2008-03-26 | $595K | — | Filing → |